Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
CStone and EQRx Enter Global Strategic Partnership for Two Immune Checkpoint Inhibitors: sugemalimab (anti-PD-L1) and CS1003 (anti-PD-1)
2020-10-27 07:23
GMAX Biopharm gives first does of anti-body drug treating PAH in phase 1B trial
2020-10-26 18:00
Sai Life Sciences to significantly expand biology capabilities at its integrated R&D campus
2020-10-26 16:35
RhoVac Participates in BIO Europe Digital
2020-10-26 16:26
Article on RhoVac's Phase I/II study to be published in November
2020-10-26 15:51
/C O R R E C T I O N -- Azura Ophthalmics/
2020-10-23 07:16
FDA Awards $1.1M Contract to CUBRC and EpiVax for Validation of New Immunoinformatic Tool for Prospective Immunogenicity Assessment of Peptide Drugs and Their Impurities
2020-10-22 21:00
Connect Biopharma to Present Additional Positive Results from the Phase 1b Study of CBP-201 for Patients with Moderate-to-Severe Atopic Dermatitis (AD) at EADV Virtual Meeting
2020-10-22 19:30
Sihuan Pharmaceutical's Gabapentin Capsules was Granted Drug Production Approval, the Third Company Obtained Approval in China
2020-10-22 10:36
Priority Review Granted to Ascentage Pharma's New Drug Application for Olverembatinib (HQP1351), the First Third-Generation BCR-ABL Inhibitor in China
2020-10-21 17:37
Cyclica to use Excelra's GOSTAR Database to develop AI & ML based Deep Learning Algorithm for Drug Target Identification
2020-10-21 10:00
One broken bone leads to another, warns IOF on World Osteoporosis Day
2020-10-21 06:18
Nanoform initiates GMP campaign for first-in-human trial of nanoformed drug by year end - ahead of schedule
2020-10-21 02:14
Key patent granted for Isla101 in Brazil
2020-10-20 03:15
Over One Thousand Psychiatrists Gather Online for Second Asia Pacific Psychiatry Symposium
2020-10-19 17:46
Xinhua Silk Road: The 51st Zhangshu National TCM Materials and Pharmaceuticals Trade Fair kicked off in the eastern Chinese city of Zhangshu
2020-10-19 17:41
Picosun's success brings Chairman of the Board Kustaa Poutiainen the National Entrepreneur Award of Finland 2020
2020-10-19 10:03
111, Inc. Teams Up with Huluwa Pharmaceutical to Explore the New Domain of "Internet + pharmaceutical"
2020-10-16 05:40
111 to be the Omni-channel Drug Commercialization Partner of Xiangxu Pharmaceutical for Traditional Chinese Medicine
2020-10-16 05:35
Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
2020-10-16 05:09
1
276
277
278
279
280
412